National Forbes feature highlights HerScan's growth, mission, and the determination behind its female-led leadership
Tampa Bay, Florida, November 2, 2026 — HerScan, a national leader in breast ultrasound screenings, is proud to announce that CEO CiCi McMullen has been featured in Forbes in an article highlighting her journey to acquire the company, overcome investment challenges, and expand access to breast health screening for women across America.
Published on October 27, 2026, the Forbes article, "She Pitched 60 Investors To Buy A Breast Screening Company," by contributor Geri Stengel, explores McMullen's determination to build upon HerScan's mission despite the challenges of securing investment in women's healthcare.
McMullen approached approximately 60 investors before successfully securing the funding to acquire HerScan in May 2025. Her commitment to the company was deeply personal, shaped by her family's experiences with breast cancer and her belief that women deserve greater access to proactive screening options.
The article also highlights a defining moment in HerScan's history. Founder Mary Jo Henderson, who established the company in 2010, prioritized finding a female leader who shared her vision for the organization's future. Although McMullen was not the highest bidder, her commitment to HerScan's mission made her the right choice to lead its next chapter.
Since the acquisition, HerScan has continued to expand its national presence, serving women across 48 states and surpassing 300,000 women screened nationwide. Forbes also highlighted the company's growing team, community-based screening model, and increasing demand for convenient breast health services.
“I just liked it because it removed the barriers to screening,” McMullen shared with Forbes, reflecting on what initially drew her to HerScan.
HerScan's approach focuses on making breast ultrasound screening more accessible through convenient community-based events, transparent pricing, and appointments that do not require a doctor's referral. These screenings complement mammography, providing women with an additional option to support their breast health.
Beyond the company's growth, the Forbes feature emphasizes a larger conversation about investment in women's health and the importance of female leadership in addressing gaps in healthcare access.
For HerScan, the recognition reflects more than a business milestone. It represents the continued importance of educating women about their breast health options, bringing screening services into communities, and empowering women to take an active role in their care.
Read the full Forbes feature: She Pitched 60 Investors To Buy A Breast Screening Company
To learn more about HerScan or find an upcoming screening, visit HerScan.com.
About HerScan
HerScan is a national provider of supplemental breast ultrasound screening services dedicated to making proactive breast health care more accessible, convenient, and affordable.
Having screened more than 300,000 women nationwide, HerScan continues to advance its mission of empowering women to take an active role in their breast health. Through community-based screening events across the United States, HerScan provides convenient access to breast ultrasound screenings performed by certified female sonographers and interpreted by board-certified radiologists.
Learn more at HerScan.com.
Media Contact
Kate Hudson
Communications Manager
k.hudson@herscan.com
(914) 554-7576